Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al

Arthritis Rheum. 2001 Aug;44(8):1966-8. doi: 10.1002/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antibodies, Antinuclear / biosynthesis*
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / immunology
  • Chemical and Drug Induced Liver Injury / complications
  • Chemical and Drug Induced Liver Injury / immunology*
  • Chemical and Drug Induced Liver Injury / pathology*
  • DNA / immunology*
  • Female
  • Humans
  • Immunoglobulin A / biosynthesis
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin M / biosynthesis
  • Infliximab
  • Liver / pathology

Substances

  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • DNA
  • Infliximab